+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bnp & Ntprobnp Market by Type (Bnp Test Kits, Ntprobnp Test Kits), Test Type (Laboratory Testing, Point-of-Care Testing), Component, Technology, Sales Channel, Application, End User - Global Forecast 2025-2030- Product Image
Bnp & Ntprobnp Market by Type (Bnp Test Kits, Ntprobnp Test Kits), Test Type (Laboratory Testing, Point-of-Care Testing), Component, Technology, Sales Channel, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Bnp & Ntprobnp Market by Type (Bnp Test Kits, Ntprobnp Test Kits), Test Type (Laboratory Testing, Point-of-Care Testing), Component, Technology, Sales Channel, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083861
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The BNP and NT-proBNP market is evolving amid rapid advances in cardiac diagnostics, growing clinical adoption, and new pressures on global supply chains. Senior leaders now face a highly dynamic landscape shaped by innovation, regulation, and regional health priorities.

Market Snapshot: BNP and NT-proBNP Market Growth and Trends

The BNP & NT-proBNP market grew from USD 1.96 billion in 2024 to USD 2.18 billion in 2025. It is expected to continue growing at a CAGR of 11.30%, reaching USD 3.73 billion by 2030. Rising awareness of cardiovascular health, the shift toward personalized medicine, and advances in biomarker assay technologies underpin this expansion. Vendors are adapting portfolios to address demand across laboratory and point-of-care settings, reinforcing diagnostic speed and accuracy as essential differentiators.

Scope & Segmentation of the BNP and NT-proBNP Market

  • Type: BNP test kits, NT-proBNP test kits
  • Test Type: Laboratory testing (chemiluminescent immunoassay, enzyme-linked immunosorbent assay), point-of-care testing
  • Component: Analyzers and devices (benchtop, portable analyzers), reagents and kits
  • Technology: Biosensors, immunoassays, microfluidics
  • Sales Channel: Offline sales, online sales
  • Application: Heart failure management (acute and chronic forms including cardiogenic shock, biventricular, left-sided, right-sided, and cor pulmonale), kidney dysfunction (acute, chronic), risk assessment (prognostic evaluation for mortality, readmission), screening for cardiovascular diseases
  • End User: Clinical laboratories (diagnostic labs, biochemistry labs, pathology labs, research labs), hospitals and clinics, research institutes and academia
  • Region: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, and additional EMEA countries), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asia, and others)
  • Companies: Abbott Laboratories, Autobio Diagnostics Co., Ltd., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., bioMérieux PLC, Chengdu Illumaxbio Technology Co., Ltd., F. Hoffmann-La Roche Ltd, Fujirebio China Co., Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., QuidelOrtho Corporation, Radiometer Medical ApS, Randox Laboratories Ltd., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Tosoh Europe N.V.

Key Takeaways for Senior Decision-Makers

  • The BNP and NT-proBNP market is rapidly transforming, driven by integration of biosensors, immunoassays, and emerging microfluidic platforms to optimize throughput and reduce turnaround time.
  • Point-of-care solutions are expanding access beyond traditional laboratories, enabling personalized risk assessment and real-time monitoring in clinical and outpatient settings.
  • Collaborations between device manufacturers and reagent developers are promoting integrated systems, while digital health integration streamlines connectivity with electronic health records for improved care coordination.
  • Regional strategies must reflect variable reimbursement structures, regulatory environments, and health infrastructure maturity. For example, the Americas prioritize large-scale EHR integration, whereas EMEA and Asia-Pacific are scaling modular, decentralized solutions.
  • Manufacturers are responding to rising compliance demands and local policy changes by reinforcing supply chain resilience, investing in local production, and accelerating validation for new assay formats and point-of-care analyzers.

Tariff Impact on BNP and NT-proBNP Diagnostics

  • The introduction of 2025 US tariff schedules on imported reagents and analyzer components will increase input costs, challenging both sourcing and pricing models across the supply chain.
  • Mitigation strategies include shifting reagent manufacturing to lower-tariff regions, pursuing multi-sourcing, and optimizing reagent consumption per test to offset cost escalations.
  • Short-term pricing challenges may affect adoption in cost-sensitive markets, but also drive longer-term innovation and process efficiency.

Methodology & Data Sources

This report leverages in-depth secondary research, peer-reviewed literature analysis, and over sixty primary interviews with industry, research, and regulatory experts. Data triangulation, scenario modeling, and consistent audit checks underpin the reliability of findings.

Why This Report Matters for Leadership

  • Enables strategic planning by revealing market-defining trends and supply chain scenarios impacting diagnostic development and investment.
  • Equips product managers and business leaders to benchmark technology, partnership, and regional opportunities within a shifting regulatory and commercial landscape.

Conclusion

Senior decision-makers can harness this research to guide informed investment, product development, and partnership strategies. Proactive adaptation to emerging trends and regulatory shifts will be essential for long-term growth in the cardiac biomarker diagnostics sector.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of point-of-care BNP and NT-proBNP diagnostics into telehealth-enabled home heart failure monitoring
5.2. Adoption of multiplex biomarker panels combining NT-proBNP with cardiac troponins for enhanced risk stratification in acute care
5.3. Development of ultra-sensitive immunoassays lowering detection thresholds for early-stage heart failure screening in primary care
5.4. Implementation of AI-driven algorithms for interpreting serial NT-proBNP measurements to predict hospitalization risk in heart failure patients
5.5. Expansion of reimbursement policies and value-based care models favoring routine BNP testing in outpatient chronic heart failure management
5.6. Standardization initiatives for BNP and NT-proBNP assays addressing inter-laboratory variability and improving cross-study comparability
5.7. Increased use of wearable biosensors and microfluidic chips for continuous BNP monitoring in high-risk cardiovascular cohorts
5.8. Emergence of noninvasive fluid sampling techniques such as saliva-based BNP tests for point-of-care heart failure assessment
5.9. Regulatory shifts accelerating approval pathways for novel NT-proBNP assays under expedited cardiovascular diagnostics programs
5.10. Biosimilar natriuretic peptide therapeutics influencing market demand and competitive dynamics for diagnostic assays
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bnp & Ntprobnp Market, by Type
8.1. Introduction
8.2. Bnp Test Kits
8.3. Ntprobnp Test Kits
9. Bnp & Ntprobnp Market, by Test Type
9.1. Introduction
9.2. Laboratory Testing
9.2.1. Chemiluminescent Immunoassay (CLIA)
9.2.2. Enzyme-linked Immunosorbent Assay (ELISA)
9.3. Point-of-Care Testing
10. Bnp & Ntprobnp Market, by Component
10.1. Introduction
10.2. Analyzers & Devices
10.2.1. Benchtop Analyzers
10.2.2. Portable Analyzers
10.3. Reagents & Kits
11. Bnp & Ntprobnp Market, by Technology
11.1. Introduction
11.2. Biosensors
11.3. Immunoassays
11.4. Microfluidics
12. Bnp & Ntprobnp Market, by Sales Channel
12.1. Introduction
12.2. Offline Sales
12.3. Online Sales
13. Bnp & Ntprobnp Market, by Application
13.1. Introduction
13.2. Heart Failure Management
13.2.1. Acute Heart Failure
13.2.1.1. Cardiogenic Shock
13.2.1.2. Decompensated Heart Failure
13.2.2. Chronic Heart Failure
13.2.2.1. Biventricular Heart Failure
13.2.2.2. Left-Sided Heart Failure
13.2.2.3. Right-Sided Heart Failure
13.2.2.3.1. Cor Pulmonale
13.3. Kidney Dysfunction
13.3.1. Acute Kidney Injury
13.3.2. Chronic Kidney Disease
13.4. Risk Assessment
13.4.1. Prognostic Evaluation
13.4.1.1. Mortality Risk Assessment
13.4.1.2. Readmission Risk Assessment
13.4.2. Screening for Cardiovascular Diseases
14. Bnp & Ntprobnp Market, by End User
14.1. Introduction
14.2. Clinical Laboratories
14.2.1. Diagnostic Laboratories
14.2.1.1. Biochemistry Labs
14.2.1.2. Pathology Labs
14.2.2. Research Laboratories
14.3. Hospitals & Clinics
14.4. Research Institutes & Academia
15. Americas Bnp & Ntprobnp Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Bnp & Ntprobnp Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Bnp & Ntprobnp Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. Autobio Diagnostics Co., Ltd.
18.3.3. Beckman Coulter, Inc.
18.3.4. Bio-Rad Laboratories, Inc
18.3.5. BioMérieux PLC
18.3.6. Chengdu Illumaxbio Technology Co., Ltd.
18.3.7. F. Hoffmann-La Roche Ltd
18.3.8. Fujirebio China Co., Ltd.
18.3.9. Gentian Diagnostics ASA
18.3.10. Getein Biotech, Inc.
18.3.11. QuidelOrtho Corporation
18.3.12. Radiometer Medical ApS
18.3.13. Randox Laboratories Ltd.
18.3.14. Siemens AG
18.3.15. Sysmex Corporation
18.3.16. Thermo Fisher Scientific Inc.
18.3.17. Tosoh Europe N.V.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BNP & NTPROBNP MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BNP & NTPROBNP MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BNP & NTPROBNP MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BNP & NTPROBNP MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BNP & NTPROBNP MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BNP & NTPROBNP MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BNP & NTPROBNP MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. BNP & NTPROBNP MARKET: RESEARCHAI
FIGURE 30. BNP & NTPROBNP MARKET: RESEARCHSTATISTICS
FIGURE 31. BNP & NTPROBNP MARKET: RESEARCHCONTACTS
FIGURE 32. BNP & NTPROBNP MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BNP & NTPROBNP MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BNP & NTPROBNP MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BNP & NTPROBNP MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BNP & NTPROBNP MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BNP & NTPROBNP MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BNP TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BNP TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BNP & NTPROBNP MARKET SIZE, BY NTPROBNP TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BNP & NTPROBNP MARKET SIZE, BY NTPROBNP TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY (CLIA), BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY (CLIA), BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BNP & NTPROBNP MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BNP & NTPROBNP MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BENCHTOP ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BENCHTOP ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PORTABLE ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PORTABLE ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BNP & NTPROBNP MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BNP & NTPROBNP MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BIOSENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BNP & NTPROBNP MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BNP & NTPROBNP MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BNP & NTPROBNP MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BNP & NTPROBNP MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BNP & NTPROBNP MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BNP & NTPROBNP MARKET SIZE, BY OFFLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BNP & NTPROBNP MARKET SIZE, BY DECOMPENSATED HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BNP & NTPROBNP MARKET SIZE, BY DECOMPENSATED HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BIVENTRICULAR HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BIVENTRICULAR HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BNP & NTPROBNP MARKET SIZE, BY LEFT-SIDED HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BNP & NTPROBNP MARKET SIZE, BY LEFT-SIDED HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COR PULMONALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BNP & NTPROBNP MARKET SIZE, BY COR PULMONALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BNP & NTPROBNP MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BNP & NTPROBNP MARKET SIZE, BY MORTALITY RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BNP & NTPROBNP MARKET SIZE, BY MORTALITY RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BNP & NTPROBNP MARKET SIZE, BY READMISSION RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BNP & NTPROBNP MARKET SIZE, BY READMISSION RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BNP & NTPROBNP MARKET SIZE, BY SCREENING FOR CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BNP & NTPROBNP MARKET SIZE, BY SCREENING FOR CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BNP & NTPROBNP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BIOCHEMISTRY LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BNP & NTPROBNP MARKET SIZE, BY BIOCHEMISTRY LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BNP & NTPROBNP MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BNP & NTPROBNP MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BNP & NTPROBNP MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RESEARCH INSTITUTES & ACADEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BNP & NTPROBNP MARKET SIZE, BY RESEARCH INSTITUTES & ACADEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BNP & NTPROBNP MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS BNP & NTPROBNP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS BNP & NTPROBNP MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES BNP & NTPROBNP MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 199. CANADA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 200. CANADA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 201. CANADA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 202. CANADA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 203. CANADA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 204. CANADA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 205. CANADA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 206. CANADA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 207. CANADA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2024 (USD MILLION)
TABLE 208. CANADA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2025-2030 (USD MILLION)
TABLE 209. CANADA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. CANADA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. CANADA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. CANADA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. CANADA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. CANADA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. CANADA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 216. CANADA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 217. CANADA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 218. CANADA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 219. CANADA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 220. CANADA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 221. CANADA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 222. CANADA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 223. CANADA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 224. CANADA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 225. CANADA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 226. CANADA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 227. CANADA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2024 (USD MILLION)
TABLE 228. CANADA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2025-2030 (USD MILLION)
TABLE 229. CANADA BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. CANADA BNP & NTPROBNP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. CANADA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 232. CANADA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 233. CANADA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 234. CANADA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 235. MEXICO BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO BNP & NTPROBNP MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 240. MEXICO BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 241. MEXICO BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 242. MEXICO BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 243. MEXICO BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2024 (USD MILLION)
TABLE 244. MEXICO BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2025-2030 (USD MILLION)
TABLE 245. MEXICO BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. MEXICO BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. MEXICO BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. MEXICO BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. MEXICO BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. MEXICO BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. MEXICO BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 252. MEXICO BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 253. MEXICO BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 254. MEXICO BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 255. MEXICO BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 256. MEXICO BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 257. MEXICO BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 258. MEXICO BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 259. MEXICO BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 260. MEXICO BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 261. MEXICO BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 262. MEXICO BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 263. MEXICO BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2024 (USD MILLION)
TABLE 264. MEXICO BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2025-2030 (USD MILLION)
TABLE 265. MEXICO BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. MEXICO BNP & NTPROBNP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. MEXICO BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 268. MEXICO BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 269. MEXICO BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 270. MEXICO BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL BNP & NTPROBNP MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL BNP & NTPROBNP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY LABORATORY TESTING, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY ANALYZERS & DEVICES, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY ACUTE HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY CHRONIC HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 332. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY KIDNEY DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 333. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 334. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY RISK ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 335. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2018-2024 (USD MILLION)
TABLE 336. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY PROGNOSTIC EVALUATION, 2025-2030 (USD MILLION)
TABLE 337. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
TABLE 340. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
TABLE 341. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 342. ARGENTINA BNP & NTPROBNP MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA BNP & NTPROBNP MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA BNP & NTPROBNP MARKET SIZE, BY TE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bnp & Ntprobnp market report include:
  • Abbott Laboratories
  • Autobio Diagnostics Co., Ltd.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc
  • bioMérieux PLC
  • Chengdu Illumaxbio Technology Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Fujirebio China Co., Ltd.
  • Gentian Diagnostics ASA
  • Getein Biotech, Inc.
  • QuidelOrtho Corporation
  • Radiometer Medical ApS
  • Randox Laboratories Ltd.
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Europe N.V.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.73 Billion
Compound Annual Growth Rate11.3%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

BNP and NTproBNP Market Report 2025 - Product Image

BNP and NTproBNP Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cardiac Marker Market by Product (Instruments, Kits, Reagents), Technology (Chemiluminescence, Elisa, Fluorescence Immunoassay), Test Mode, End User, Application - Global Forecast 2025-2030 - Product Image

Cardiac Marker Market by Product (Instruments, Kits, Reagents), Technology (Chemiluminescence, Elisa, Fluorescence Immunoassay), Test Mode, End User, Application - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Cardiac Biomarker Market by Biomarker Type (BNP & NT-proBNP, Creatine Kinase (CK) MB, Myoglobin), Clinical Setting (Laboratory Testing, Point Of Care Testing), Application, End User - Global Forecast 2025-2030 - Product Image

Cardiac Biomarker Market by Biomarker Type (BNP & NT-proBNP, Creatine Kinase (CK) MB, Myoglobin), Clinical Setting (Laboratory Testing, Point Of Care Testing), Application, End User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type (Troponin, CK-MB, Myoglobin, BNP), Application (Myocardial Infarction, Congestive Heart Failure), and End User (Laboratory Testing, POC Testing ) - Global Forecast to 2031 - Product Image

Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type (Troponin, CK-MB, Myoglobin, BNP), Application (Myocardial Infarction, Congestive Heart Failure), and End User (Laboratory Testing, POC Testing ) - Global Forecast to 2031

  • Report
  • 165 Pages
  • Global
From
Cardiac Biomarkers Market Report by Type, Location of Testing, Application, and Region 2025-2033 - Product Image

Cardiac Biomarkers Market Report by Type, Location of Testing, Application, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.